U.S. flag

An official website of the United States government

NM_000492.4(CFTR):c.1766+1G>C AND not specified

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Dec 18, 2018
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001000966.8

Allele description [Variation Report for NM_000492.4(CFTR):c.1766+1G>C]

NM_000492.4(CFTR):c.1766+1G>C

Gene:
CFTR:CF transmembrane conductance regulator [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
7q31.2
Genomic location:
Preferred name:
NM_000492.4(CFTR):c.1766+1G>C
Other names:
1898+1G->C
HGVS:
  • NC_000007.14:g.117590440G>C
  • NG_016465.4:g.129657G>C
  • NM_000492.4:c.1766+1G>CMANE SELECT
  • LRG_663t1:c.1766+1G>C
  • LRG_663:g.129657G>C
  • NC_000007.13:g.117230494G>C
  • NM_000492.3:c.1766+1G>C
Links:
dbSNP: rs121908748
NCBI 1000 Genomes Browser:
rs121908748
Molecular consequence:
  • NM_000492.4:c.1766+1G>C - splice donor variant - [Sequence Ontology: SO:0001575]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001158065ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
criteria provided, single submitter

(ARUP Molecular Germline Variant Investigation Process)
Pathogenic
(Dec 18, 2018)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories, SCV001158065.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The CFTR c.1766+1G>C variant (rs121908748) is reported in the literature in individuals affected with pancreatic-insufficient cystic fibrosis (Cuppens 1993, Zietkiewicz 2014, CFTR2 database) and was identified in trans to p.Phe508del in at least one affected individual (Zietkiewicz 2014). The c.1766+1G>C variant is found on a single chromosome in the Genome Aggregation Database, indicating it is not a common polymorphism, and it is reported as pathogenic by several laboratories in ClinVar (Variation ID: 53376). This variant abolishes the canonical splice donor site of intron 12, which is likely to disrupt gene function. Based on available information, this variant is considered to be severely pathogenic. References: CFTR2 database: https://cftr2.org/ Cuppens H et al. Detection of 98.5% of the mutations in 200 Belgian cystic fibrosis alleles by reverse dot-blot and sequencing of the complete coding region and exon/intron junctions of the CFTR gene. Genomics. 1993 Dec;18(3):693-7. Zietkiewicz E et al. CFTR mutations spectrum and the efficiency of molecular diagnostics in Polish cystic fibrosis patients. PLoS One. 2014 Feb 26;9(2):e89094.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024